References
- Caramelo C, Espinosa G, Manzarbeitia F, Cernadas M R, Perez Tejerizo G, Tan D, Mosquera J R, Digiuni E, Monton M, Millas I, Hernando L, Casado S, Lopez‐Farre A. Role of endothelium‐related mechanisms in the pathophysiology of renal ischemia/reperfusion in normal rabbits. Circ Res 1996; 79: 1031–1038, [PUBMED], [INFOTRIEVE], [CSA]
- Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatin‐induced acute renal failure in rats. J Lab Clin Med 1998; 131: 518–526, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rey F E, Li X C, Carretero O A, Garvin J L, Pagano P J. Perivascular superoxide anion contributes to impairment of endothelium‐dependent relaxation: role of gp91 (phox). Circulation 2002; 106: 2497–2502, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schnackenberg C G, Wilcox C S. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 2001; 59: 1859–1864, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shastri S, Gopalakrishnan V, Poduri R, Wang H D. Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats. J Hypertens 2002; 20: 1381–1391, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov A L, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002; 90: E58–E65, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Navar L G. Integrating multiple paracrines regulators of renal microvascular dynamics. Am J Physiol 1998; 274: F433–F444, [PUBMED], [INFOTRIEVE]
- Ito S, Johnson C S, Carretero O A. Modulation of angiotensin II‐induced vasoconstriction by endothelium‐derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1991; 87: 1656–1663, [PUBMED], [INFOTRIEVE]
- Hayashi K, Epstein M, Loutzenhiser R. Enhanced myogenic responsiveness of renal interlobular arteries in spontaneously hypertensive rats. Hypertension 1992; 19: 153–160, [PUBMED], [INFOTRIEVE]
- Hayashi K, Loutzenhiser R, Epstein M, Suzuki H, Saruta T. Multiple factors contribute to acetylcholine‐induced renal afferent arteriolar vasodilation during myogenic and norepinephrine‐ and KCl‐induced vasoconstriction. Studies in the isolated perfused hydronephrotic kidney. Circ Res 1994; 75: 821–828, [PUBMED], [INFOTRIEVE], [CSA]
- Loutzenhiser R, Hayashi K, Epstein M. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney. J Pharmacol Exp Ther 1988; 246: 522–528, [PUBMED], [INFOTRIEVE]
- Epstein M, Flamenbaum W, Loutzenhiser R. Characterization of the renin‐angiotensin system in the isolated perfused kidney. Renal Physiol 1980; 2: 244–256
- Gryglewski R J, Palmer R MJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium‐derived vascular relaxing factor. Nature 1986; 15: 170–179
- Siragy H M, Jaffa A A, Margolius H S, Carey R M. Renin‐angiotensin system modulates renal bradykinin production. Am J Physiol 1996; 271: R1090–R1095, [PUBMED], [INFOTRIEVE]
- Laursen J B, Rajagopalan S, Galis Z, Tarpey M, Freeman B A, Harrison D G. Role of superoxide in angiotensin II‐induced but not catecholamine‐induced hypertension. Circulation 1997; 95: 588–593, [PUBMED], [INFOTRIEVE], [CSA]
- Kawazoe T, Kosaka H, Yoneyama H, Hata Y. Acute production of vascular superoxide by angiotensin II but not by catecholamines. J Hypertens 2000; 18: 179–185, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ito S, Arima S, Ren Y L, Juncos L A, Carretero O A. Endothelium‐derived relaxing/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 1993; 91: 2012–2019, [PUBMED], [INFOTRIEVE]
- Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothelium‐derived hyperpolarizing factor in mice. J Clin Invest 2000; 106: 1521–1530, [PUBMED], [INFOTRIEVE], [CSA]